Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Pia Cicalese

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Science Translational Medicine|May 1, 2024
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndromeGiulia Consiglieri, Francesca Tucci, Maurizio De Pellegrin, et al.
Frontiers in Immunology|January 10, 2022
Rubella Virus Infected Macrophages and Neutrophils Define Patterns of Granulomatous Inflammation in Inborn and Acquired Errors of ImmunityLudmila Perelygina, Raeesa Faisthalab, Emily Abernathy, et al.
Lancet (London, England)|January 23, 2022
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded accessFrancesca Fumagalli, Valeria Calbi, Maria Grazia Natali Sora, et al.
Blood|September 27, 2018
T-cell defects in patients with <i>ARPC1B</i> germline mutations account for combined immunodeficiencyImmacolata Brigida, Matteo Zoccolillo, Maria Pia Cicalese, et al.
The New England Journal of Medicine|November 17, 2021
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler SyndromeBernhard Gentner, Francesca Tucci, Stefania Galimberti, et al.
The New England Journal of Medicine|April 23, 2025
Long-Term Effects of Atidarsagene Autotemcel for Metachromatic LeukodystrophyFrancesca Fumagalli, Valeria Calbi, Vera Gallo, et al.
Journal of Clinical Immunology|July 29, 2021
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 PatientsHasan Hashem, Giorgia Bucciol, Seza Ozen, et al.
European Journal of Immunology|May 14, 2022
Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiencyGiulia Milardi, Biagio Di Lorenzo, Jolanda Gerosa, et al.
Journal of Clinical Immunology|May 2, 2022
Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 PatientsHasan Hashem, Giorgia Bucciol, Seza Ozen, et al.
Nature Medicine|February 15, 2024
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiencyMaddalena Migliavacca, Federica Barzaghi, Claudia Fossati, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Science Translational Medicine|May 1, 2024
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndromeGiulia Consiglieri, Francesca Tucci, Maurizio De Pellegrin, et al.
Frontiers in Immunology|January 10, 2022
Rubella Virus Infected Macrophages and Neutrophils Define Patterns of Granulomatous Inflammation in Inborn and Acquired Errors of ImmunityLudmila Perelygina, Raeesa Faisthalab, Emily Abernathy, et al.
Lancet (London, England)|January 23, 2022
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded accessFrancesca Fumagalli, Valeria Calbi, Maria Grazia Natali Sora, et al.
Blood|September 27, 2018
T-cell defects in patients with <i>ARPC1B</i> germline mutations account for combined immunodeficiencyImmacolata Brigida, Matteo Zoccolillo, Maria Pia Cicalese, et al.
The New England Journal of Medicine|November 17, 2021
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler SyndromeBernhard Gentner, Francesca Tucci, Stefania Galimberti, et al.
The New England Journal of Medicine|April 23, 2025
Long-Term Effects of Atidarsagene Autotemcel for Metachromatic LeukodystrophyFrancesca Fumagalli, Valeria Calbi, Vera Gallo, et al.
Journal of Clinical Immunology|July 29, 2021
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 PatientsHasan Hashem, Giorgia Bucciol, Seza Ozen, et al.
European Journal of Immunology|May 14, 2022
Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiencyGiulia Milardi, Biagio Di Lorenzo, Jolanda Gerosa, et al.
Journal of Clinical Immunology|May 2, 2022
Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 PatientsHasan Hashem, Giorgia Bucciol, Seza Ozen, et al.
Nature Medicine|February 15, 2024
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiencyMaddalena Migliavacca, Federica Barzaghi, Claudia Fossati, et al.
Pageof 10